A prospective multicenter octreotide dose response study in the treatment of acromegaly

Journal of Endocrinological Investigation

Volumn 18, Issue 5, 1995, Pages 364-369

  Ezzat, Shereen ^a   Redelmeier, D A ^a   Gnehm, M ^b   Harris, A G ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Acromegaly; growth hormone; insulin like growth factor 1; octreotide; pituitary tumor; somatostatin

Indexed keywords

GROWTH FACTOR; OCTREOTIDE; PROLACTIN; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ABDOMINAL DISCOMFORT; ACROMEGALY; ADULT; ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; FEMALE; FLATULENCE; GALLSTONE; GROWTH HORMONE BLOOD LEVEL; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PROLACTIN BLOOD LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

ACROMEGALY; ADULT; AMINO ACID SEQUENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; HORMONES, SYNTHETIC; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; OCTREOTIDE; PITUITARY NEOPLASMS; PROLACTIN; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0029038330     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03347839     Document Type: Article

References (22)

1. Acromegaly. Clinical and biochemical features in 500 patients
2. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas in a series of 214 patients
3. Conventional supervoltage irradiation is an effective treatment for acromegaly
4. Therapeutic options in acromegaly
5. Growth hormone-releasing hormone transcripts in human pituitary adenomas
6. Presence and characterization of the somatostatin precursor in normal human pituitary and in growth hormone secreting adenomas
7. SMS 201–995. A very potent and selective octapeptide analog of somatostatin with prolonged action
8. Octreotide treatment of acromegaly: A randomized multicenter study
9. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide
10. Long term effect of incremental doses of the somatostatin analog SMS 201–995 in 58 acromegalic patients
11. Growth hormone; normal synthesis, control and mechanism of action
12. Short-term treatment of acromegaly with the somatostatin analog octreotide: The first double-blind randomized placebo-controlled study on its effects
13. Comparison of the effectiveness of 2-hourly versus 8-hourly subcutaneous injections of a somatostatin analog (SMS 201–995) in the treatment of acromegaly
14. Octreotide by Intermittent Subcutaneous Injections versus Subcutaneous Infusion in Acromegaly
15. Pathophysiology of acromegaly
16. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line
17. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status
18. Somatostatin
19. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas
20. Postprandial gallbladder motility long-term treatment with the long-acting somatostatin analog SMS 201–995 in acromegaly
21. Pancreatic exocrine and gallbladder function during long-term treatment with octreotide (SMS 201–995)
22. Gallstones and treatment with octreotide for acromegaly